FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1485-1487 April 7, 2005 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Fridkin, S. K. Related Article by Miller, L. G. PubMed Citation

Laypeople and health care professionals alike recognize Staphylococcus aureus as an important cause of disease and understand that antibiotic-resistant strains pose a threat to the community. Before the availability of antibiotics, invasive staphylococcal disease was often fatal, and the introduction of penicillin in the 1940s dramatically improved survival. Although penicillinase-producing strains soon emerged, methicillin and other penicillinase-stable -lactam agents filled the breach. However, methicillin-resistant strains of S. aureus (MRSA), which are resistant to the entire class of -lactam agents, were identified almost immediately and are now found in hospitals worldwide. Despite the growing prevalence of MRSA in hospitals, these strains . . . [Full Text of this Article]

Source Information

From the Division of Infectious Diseases, San Francisco General Hospital, University of California–San Francisco, San Francisco.

This article has been cited by other articles:

• Wirtz, C., Witte, W., Wolz, C., Goerke, C. (2009). Transcription of the phage-encoded Panton-Valentine leukocidin of Staphylococcus aureus is dependent on the phage life-cycle and on the host background. Microbiology 155: 3491-3499 [Abstract] [Full Text]  
• Llarrull, L. I., Fisher, J. F., Mobashery, S. (2009). Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New {beta}-Lactams That Meet the Challenge. Antimicrob. Agents Chemother. 53: 4051-4063 [Full Text]  
• Kosowska-Shick, K., Clark, C., Pankuch, G. A., McGhee, P., Dewasse, B., Beachel, L., Appelbaum, P. C. (2009). Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies. Antimicrob. Agents Chemother. 53: 4217-4224 [Abstract] [Full Text]  
• Eguchi, K., Kanazawa, K., Eriguchi, Y., Ueda, Y. (2009). Pharmacodynamics of SMP-601 (PTZ601) against Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus in Neutropenic Murine Thigh Infection Models. Antimicrob. Agents Chemother. 53: 3391-3398 [Abstract] [Full Text]  
• Deger, G. E., Quick, D. W. (2009). The Enduring Menace of MRSA: Incidence, Treatment, and Prevention in a County Jail. J Correct Health Care 15: 174-178 [Abstract]  
• Li, M., Diep, B. A., Villaruz, A. E., Braughton, K. R., Jiang, X., DeLeo, F. R., Chambers, H. F., Lu, Y., Otto, M. (2009). From the Cover: Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 106: 5883-5888 [Abstract] [Full Text]  
• Perez-Vazquez, M., Vindel, A., Marcos, C., Oteo, J., Cuevas, O., Trincado, P., Bautista, V., Grundmann, H., Campos, J., on behalf of the EARSS Spain spa-typing Group, (2009). Spread of invasive Spanish Staphylococcus aureus spa-type t067 associated with a high prevalence of the aminoglycoside-modifying enzyme gene ant(4')-Ia and the efflux pump genes msrA/msrB. J Antimicrob Chemother 63: 21-31 [Abstract] [Full Text]  
• Sakwinska, O., Kuhn, G., Balmelli, C., Francioli, P., Giddey, M., Perreten, V., Riesen, A., Zysset, F., Blanc, D. S., Moreillon, P. (2009). Genetic Diversity and Ecological Success of Staphylococcus aureus Strains Colonizing Humans. Appl. Environ. Microbiol. 75: 175-183 [Abstract] [Full Text]  
• Dai, C., Ma, Y., Zhao, Z., Zhao, R., Wang, Q., Wu, Y., Cao, Z., Li, W. (2008). Mucroporin, the First Cationic Host Defense Peptide from the Venom of Lychas mucronatus. Antimicrob. Agents Chemother. 52: 3967-3972 [Abstract] [Full Text]  
• Spellberg, B., Ibrahim, A. S., Yeaman, M. R., Lin, L., Fu, Y., Avanesian, V., Bayer, A. S., Filler, S. G., Lipke, P., Otoo, H., Edwards, J. E. Jr. (2008). The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus. Infect. Immun. 76: 4574-4580 [Abstract] [Full Text]  
• Wargo, K. A., Eiland, E. H. III, Eiland, L. S. (2008). Management and Treatment Considerations for Infections Caused by Methicillin-Resistant Staphylococcus aureus. Journal of Pharmacy Practice 21: 324-336 [Abstract]  
• Zhanel, G. G., DeCorby, M., Laing, N., Weshnoweski, B., Vashisht, R., Tailor, F., Nichol, K. A., Wierzbowski, A., Baudry, P. J., Karlowsky, J. A., Lagace-Wiens, P., Walkty, A., McCracken, M., Mulvey, M. R., Johnson, J., The Canadian Antimicrobial Resistance Alliance (CA, , Hoban, D. J. (2008). Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006. Antimicrob. Agents Chemother. 52: 1430-1437 [Abstract] [Full Text]  
• Sing, A., Tuschak, C., Hormansdorfer, S. (2008). Methicillin-Resistant Staphylococcus aureus in a Family and Its Pet Cat. NEJM 358: 1200-1201 [Full Text]  
• Feder, H. M. Jr (2008). Occult Methicillin-Resistant Staphylococcus aureus Abscesses in 2 Pediatric Patients. CLIN PEDIATR 47: 176-179 [Abstract]  
• Kennedy, A. D., Otto, M., Braughton, K. R., Whitney, A. R., Chen, L., Mathema, B., Mediavilla, J. R., Byrne, K. A., Parkins, L. D., Tenover, F. C., Kreiswirth, B. N., Musser, J. M., DeLeo, F. R. (2008). From the Cover: Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification. Proc. Natl. Acad. Sci. USA 105: 1327-1332 [Abstract] [Full Text]  
• Palazzolo-Ballance, A. M., Reniere, M. L., Braughton, K. R., Sturdevant, D. E., Otto, M., Kreiswirth, B. N., Skaar, E. P., DeLeo, F. R. (2008). Neutrophil Microbicides Induce a Pathogen Survival Response in Community-Associated Methicillin-Resistant Staphylococcus aureus. J. Immunol. 180: 500-509 [Abstract] [Full Text]  
• Olszewski, M. A., Falkowski, N. R., Surana, R., Sonstein, J., Hartman, A., Moore, B. B., Huffnagle, G. B., Toews, G. B. (2007). Effect of Laparotomy on Clearance and Cytokine Induction in Staphylococcus aureus infected Lungs. Am. J. Respir. Crit. Care Med. 176: 921-929 [Abstract] [Full Text]  
• Jones, R. N., Nilius, A. M., Akinlade, B. K., Deshpande, L. M., Notario, G. F. (2007). Molecular Characterization of Staphylococcus aureus Isolates from a 2005 Clinical Trial of Uncomplicated Skin and Skin Structure Infections. Antimicrob. Agents Chemother. 51: 3381-3384 [Abstract] [Full Text]  
• Andes, D., Craig, W. A. (2007). In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin. Antimicrob. Agents Chemother. 51: 1633-1642 [Abstract] [Full Text]  
• Pucci, M. J., Cheng, J., Podos, S. D., Thoma, C. L., Thanassi, J. A., Buechter, D. D., Mushtaq, G., Vigliotti, G. A. Jr., Bradbury, B. J., Deshpande, M. (2007). In Vitro and In Vivo Antibacterial Activities of Heteroaryl Isothiazolones against Resistant Gram-Positive Pathogens. Antimicrob. Agents Chemother. 51: 1259-1267 [Abstract] [Full Text]  
• Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Vazquez, V., Hook, M., Etienne, J., Vandenesch, F., Bowden, M. G. (2007). Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia. Science 315: 1130-1133 [Abstract] [Full Text]  
• Hawkes, M., Barton, M., Conly, J., Nicolle, L., Barry, C., Ford-Jones, E. L. (2007). Community-associated MRSA: Superbug at our doorstep. CMAJ 176: 54-56 [Full Text]  
• Bonnstetter, K. K., Wolter, D. J., Tenover, F. C., McDougal, L. K., Goering, R. V. (2007). Rapid Multiplex PCR Assay for Identification of USA300 Community-Associated Methicillin-Resistant Staphylococcus aureus Isolates. J. Clin. Microbiol. 45: 141-146 [Abstract] [Full Text]  
• Phillips, S., MacDougall, C., Holdford, D. A (2007). Analysis of Empiric Antimicrobial Strategies for Cellulitis in the Era of Methicillin-Resistant Staphylococcus aureus. The Annals of Pharmacotherapy 41: 13-20 [Abstract] [Full Text]  
• Hopkins, A., Lahiri, T., Salerno, R., Heath, B. (2006). Changing Epidemiology of Life-Threatening Upper Airway Infections: The Reemergence of Bacterial Tracheitis. Pediatrics 118: 1418-1421 [Abstract] [Full Text]  
• Gilbert, M., MacDonald, J., Gregson, D., Siushansian, J., Zhang, K., Elsayed, S., Laupland, K., Louie, T., Hope, K., Mulvey, M., Gillespie, J., Nielsen, D., Wheeler, V., Louie, M., Honish, A., Keays, G., Conly, J. (2006). Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 175: 149-154 [Abstract] [Full Text]  
• Allen, U. D. (2006). Public health implications of MRSA in Canada. CMAJ 175: 161-161 [Full Text]  
• Moellering, R. C. Jr. (2006). The growing menace of community-acquired methicillin-resistant Staphylococcus aureus.. ANN INTERN MED 144: 368-370 [Full Text]  
• Peterson, L. R., Singh, K. (2006). Universal Patient Disinfection as a Tool for Infection Control: Rub-A-Dub-Dub, No Need for a Tub. Arch Intern Med 166: 274-276 [Full Text]  
• Roberts, J. C., Krueger, R. L., Peak, K. K., Veguilla, W., Cannons, A. C., Amuso, P. T., Cattani, J. (2006). Community-Associated Methicillin-Resistant Staphylococcus aureus Epidemic Clone USA300 in Isolates from Florida and Washington. J. Clin. Microbiol. 44: 225-226 [Abstract] [Full Text]  
• Short, B. R. D., Vargas, M. A., Thomas, J. C., O'Hanlon, S., Enright, M. C. (2006). In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 57: 104-109 [Abstract] [Full Text]  
• Todd, J. K. (2005). Staphylococcal Infections. Pediatr. Rev. 26: 444-450 [Full Text]  
• McAleese, F., Murphy, E., Babinchak, T., Singh, G., Said-Salim, B., Kreiswirth, B., Dunman, P., O'Connell, J., Projan, S. J., Bradford, P. A. (2005). Use of Ribotyping To Retrospectively Identify Methicillin-Resistant Staphylococcus aureus Isolates from Phase 3 Clinical Trials for Tigecycline That Are Genotypically Related to Community-Associated Isolates. Antimicrob. Agents Chemother. 49: 4521-4529 [Abstract] [Full Text]  
• Voyich, J. M., Braughton, K. R., Sturdevant, D. E., Whitney, A. R., Said-Salim, B., Porcella, S. F., Long, R. D., Dorward, D. W., Gardner, D. J., Kreiswirth, B. N., Musser, J. M., DeLeo, F. R. (2005). Insights into Mechanisms Used by Staphylococcus aureus to Avoid Destruction by Human Neutrophils. J. Immunol. 175: 3907-3919 [Abstract] [Full Text]  
• Boyle-Vavra, S., Ereshefsky, B., Wang, C.-C., Daum, R. S. (2005). Successful Multiresistant Community-Associated Methicillin-Resistant Staphylococcus aureus Lineage from Taipei, Taiwan, That Carries Either the Novel Staphylococcal Chromosome Cassette mec (SCCmec) Type VT or SCCmec Type IV. J. Clin. Microbiol. 43: 4719-4730 [Abstract] [Full Text]  
• Tietz, A., Frei, R., Widmer, A. F. (2005). Transatlantic Spread of the USA300 Clone of MRSA. NEJM 353: 532-533 [Full Text]  
• Hovell, M, Daniel, J (2005). Defining residential tobacco home policies: a behavioural and cultural perspective. Arch. Dis. Child. 90: 661-662 [Full Text]  
• (2005). Journal Watch. Arch. Dis. Child. 90: 766-767 [Full Text]  
• Bauchner, H. (2005). Atoms. Arch. Dis. Child. 90: 661-661 [Full Text]  
• (2005). Community-Acquired MRSA Enters U.S. Hospitals. JWatch Gastroenterology 2005: 8-8 [Full Text]  
• (2005). MRSA: Moving into the Community. JWatch Emergency Med. 2005: 2-2 [Full Text]  
• (2005). Community-Associated MRSA: The March Continues. JWatch Pediatrics 2005: 1-1 [Full Text]  
• (2005). Community-Acquired MRSA: Unraveling Its Disease Spectrum. JWatch Infect. Diseases 2005: 1-1 [Full Text]  
• (2005). Community-Acquired MRSA Enters U.S. Hospitals. JWatch General 2005: 1-1 [Full Text]